NHS NHS
Company Profile ↓Company Overview
NHS (NHS) is a publicly traded company listed on with a market capitalization of $186.95M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.26.
Generates positive free cash flow, funding growth and shareholder returns internally.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -7.25% |
| 6 Months: | -14.12% |
| 3 Months: | -1.61% |
| 1 Month: | -0.82% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)42.47 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Balance Sheet (Annual)
Figures in USD.
| Metric | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 295.32M | 303.91M | 323.58M | 339.80M |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Receivables | - | 6.17M | 7.91M | 5.77M | 5.59M |
| Total Liabilities | - | 127.04M | 109.48M | 89.44M | 106.51M |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 45.89M | 66.00M | 43.50M | 61.00M |
| Total Equity | - | 168.28M | 194.43M | 234.14M | 233.29M |
| Shares Outstanding | - | 19.54M | 26.08M | 29.92M | 31.53M |
Cash Flows (Annual)
Figures in USD.
| Metric | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -48.69M | -5.85M | 21.10M | 3.62M |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | - | 47.18M | 6.45M | -20.73M | -3.60M |
| Capital Expenditure | - | - | - | - | - |
| Free Cash Flow | - | -48.69M | -5.85M | 21.10M | 3.62M |
| Net Change in Cash | - | -1.51M | 599.04K | 379.43K | 21.75K |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NHS
Neuberger High Yield Strategies Fund Inc. (NHS) sees Bank of America buy $100K-a-share preferreds - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxOSzJzMVBHX0NXWU0wS082NFc2cEpuZHVyX25NdlBaTjZYemlSYkMxb2x0Q1NqOXNwVWlYNERDY205eUVyRHZ1Z3l6MzRxOEhpZTBZTnZ2bXlVUFlpenhtemloRkFZN3JPeEdndFhxMjdpX0VjbHBHSWlLTDBkMGFQV3NmdkIzWGFMalpUUE…
Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS) Stock Price Passes Below 200 Day Moving Average - Here's Why - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMiigJBVV95cUxPM2NvNk5EVkVVZm54VlpxRnFiVWlyczhDa3Y0eEYyck5xNnhWVnQxOW5yd3ppeEJUU0VjU3hRQzI5VFlkbGtHZVA5YzEyOWdqcG1zbU5EaVpOako1MTI1VTAtQTY3Y3VOMEd6dTQ2U3o3SXcwM0ZXdVBmWXA2Qi1tOHVSWUNnVXZESzNkWD…
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES RIGHTS OFFERING AND SUMMARY OF TERMS - PR Newswire
<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxNVmxFLUdGelV4Z09TLTRXb09aR2JROXRNY2x0ZkJHN2pYNjVvQnRVdGYyTmppdHlDcVpTMzFieGpxRlRoOGcxaF9nQlc1NnIyb1FFb01ZY3BaanlURW9VdlJ0R2VmVFdGODVJQ1VRaXpDVC02QUN0eE8zak84NU1SaEJtNXFHY0RSY29yZE…
Novo's Wegovy cleared by UK drug price watchdog for heart disease, expanding access by 1.2 million people - CNBC
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxPdU82R0haMTBXazAyNV9XY09nNzNfMGFhclFTbmNrdS1mMWZ0NVNzT0QyWXBjdjJxMS1aNjBnQ2NtUUhYNi1uaWpqTW5aaDFSU1A5YUpaSlpQS0x3WF9kTVd5WUNWVUJuZjVaTFZ2LUViSGJWVlVId2lhaWRyd3ZBRTBHWkpPclIzMzNB0g…
NHS: Too Expensive Given The Unsustainable Distribution And Bond Market Troubles - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOalBxZDNxeXoxbHNZZUFXNDRFQTFzSUNtR3hqa3VXNkZjc0tzWEN1bHpWaHpUTm5sdnZyb29fVlRIczF1MElZX1paVFVqVjFnbUJFS1FwTEx5VEpLQWwzMk8wMlhIZ0ZTWUhIa3MxMXRIdlc4OW9GSXp1VC1QM1pXZ3k4UXV1M2ZGM09udX…
Grail stock craters as key NHS-Galleri cancer blood test trial fails to hit primary endpoint - Fierce Biotech
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPcFgzb0xVWkxUUEhyY3VfY3llNWt5MldYVmlBYkVBb3RUVGo0bXVLTkdkUHBpZUloNWdJa3pBZElYTUxTemhva2Mxc3JIelRkMVJhX1p5TE9xOGdiNXNFZTFlQ0N4ajRBSHozb05iUVJuendTSXRiS3kyMHZ1SDJDNzh4YU9naXRKbWV6TF…
NHS — Frequently Asked Questions
What is the current share price of NHS?
As of 2026-09-07 16:24 PDT, NHS trades at $5.93 on NASDAQ/NYSE. Its 52-week range is $5.86 to $7.10.
What is the market capitalisation of NHS?
NHS has a market capitalisation of $186.95M on NASDAQ/NYSE.
Is NHS a good stock to buy?
This page provides a data-driven analysis of NHS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.